Automation Testing In RTSM Software: What It Is, And Why It Can Impact Your Trial Timelines And System Quality
By Chuck Harris, Founder and COO, Korio

As clinical trial designs evolve into highly sophisticated, adaptive models, the traditional "manual" approach to Randomization and Trial Supply Management (RTSM) is struggling to keep pace. Relying solely on human testers to verify thousands of logic combinations in a system-in-flux often leads to a game of "whack-a-mole" rather than true validation. To ensure system integrity, the industry is shifting toward automated testing frameworks that provide a systematic, repeatable way to manage complexity.
By integrating automated scripts into the delivery lifecycle, teams can verify end-to-end workflows, simulate exhaustive user entry combinations, and generate objective testing evidence. This doesn't replace human expertise; rather, it liberates specialists from repetitive tasks, allowing them to focus on nuanced protocol amendments and creative problem-solving. Embracing this technology-agnostic discipline means faster mid-study changes, more reliable UAT, and quantifiable risk mitigation. Moving beyond the legacy of manual oversight ensures that the RTSM infrastructure is as scientifically advanced as the life-saving medicines it helps develop.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.